U.S. Biotech Stock News

Recent share performance and business snapshot Occidental Petroleum (OXY) has drawn investor attention after a recent share price move, with the stock last closing at $66.24, set against a value score of 2 and an intrinsic discount estimate of 42.71%. See our latest analysis for Occidental Petroleum. The recent 1-month share price return of 24.79% and 90-day share price return of 59.77% point to strong positive momentum. The 1-year total shareholder return of 37.10% and 5-year total...

In recent weeks, gold prices have swung as easing U.S.–Iran tensions, a stronger U.S. dollar and profit‑taking offset concerns about the U.S.’s roughly US$42.00 trillion net fiscal deficit and rising Treasury yields, which together keep gold’s role as a hedge in focus for investors. As the world’s largest gold producer, Newmont has sat at the center of these shifting speculative flows into and out of gold, with its cost efficiencies and dividend profile drawing investors who are reassessing...

Over the last 7 days, the United States market has dropped 3.5%, yet it has seen a rise of 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these growth opportunities.

AbbVie’s Allergan Aesthetics unit is running its fourth annual CoolMonth promotion in April 2026, offering new patients discounts on CoolSculpting treatments. The company highlighted new aesthetics data at the American Academy of Dermatology meeting, including a next generation neurotoxin candidate. AbbVie reported emerging trends such as GLP-1 users entering the aesthetics segment and patient concerns about cost and unnatural looking results. For NYSE:ABBV, this CoolMonth campaign...

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year with anticipated earnings growth of 15% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading below their estimated worth can provide opportunities for investors seeking value amidst broader market trends.

If you are wondering whether AT&T's current price really reflects what you are getting as a shareholder, you are asking the right question. AT&T recently closed at US$28.78, with returns of 0.1% over 7 days, 2.7% over 30 days, 17.2% year to date and 6.2% over the last year. This gives you a useful starting point for judging value. Recent coverage around AT&T has focused on its role as a major U.S. telecom provider and how it fits into long term connectivity trends. This context helps frame...

S&P Global has appointed Firdaus Bhathena as Executive Vice President and Chief Technology and Transformation Officer, while also facing shareholder proposals on special meeting rights and charitable giving oversight ahead of its May 20, 2026 annual meeting. This combination of a senior technology hire and active governance-focused shareholders highlights how digital transformation and investor scrutiny are shaping S&P Global’s next phase. We’ll now examine how Bhathena’s technology and...

Over the last 7 days, the United States market has experienced a 3.5% decline, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may offer resilience amid market fluctuations.

Progressive (NYSE:PGR) has completed two major fixed income offerings totaling more than $1.4b in senior unsecured notes. The new notes mature in 2031 and 2036, adding longer dated debt to the company’s capital structure. AM Best assigned an 'a' (Excellent) credit rating and a stable outlook to these new unsecured notes. Progressive, trading at $201.39, comes into this debt issuance with a mixed share price record, including a 24.2% decline over the past year and gains of 51.9% over three...

Philip Morris International (NYSE:PM) has released its Value Report 2025, outlining updated priorities across its smoke free transition. The company has also introduced its Value Plan 2030+, setting new long term focus areas for consumer health impact, climate, biodiversity, and workforce well being. These disclosures expand on prior transformation efforts by linking sustainability goals with business planning and capital allocation over the coming years. For investors following NYSE:PM,...

Over the last 7 days, the United States market has dropped 3.5%, but it has seen a rise of 14% over the past year, with earnings projected to grow by 15% annually in coming years. In light of these conditions, identifying stocks with strong financial health and growth potential is crucial for investors seeking opportunities beyond mainstream options. Penny stocks, though an outdated term, still represent a niche investment area that can offer surprising value and potential returns when backed...

Why WisdomTree is on investors’ radar today WisdomTree (WT) has attracted fresh attention after recent share price swings, with a month return of 18.6% decline contrasting with a 12.1% gain over the past 3 months and 57.6% total return over the past year. See our latest analysis for WisdomTree. The recent 18.6% 1 month share price decline contrasts with double digit 3 month gains and a strong multi year total shareholder return. This may indicate a pause in momentum rather than a clear shift...

McCormick (NYSE:MKC) is in advanced talks to combine with Unilever's food business, signaling a potential landmark merger in the global packaged food sector. The deal discussions are described as being in a late stage, with an announcement viewed as relatively near term. The combination would reshape McCormick's brand mix and global footprint, creating a much larger player in spices, seasonings, and pantry staples. For investors watching McCormick, the timing of these talks comes after a...

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this dynamic environment, identifying stocks that are not only resilient but also poised for growth can be a rewarding strategy for investors seeking potential opportunities.

Over the last 7 days, the United States market has experienced a 3.5% drop, although it has shown resilience with a 14% rise over the past year and an earnings growth forecast of 15% annually. In this context, dividend stocks that offer consistent payouts and potential for long-term appreciation can be attractive options for investors seeking stability amidst fluctuating market conditions.

What Trump Media & Technology Group’s recent trading performance signals for investors With no single headline event driving attention, Trump Media & Technology Group (DJT) has been drawing interest mainly because of its trading performance, including a 1 day gain of 2.95% and a month decline of 18.58%. See our latest analysis for Trump Media & Technology Group. That recent 1 day 2.95% share price gain sits against a weaker backdrop, with the 30 day share price return of 18.58% and year to...

JPMorgan Chase (NYSE:JPM) has launched the American Dream Initiative, a multi year nationwide program for U.S. small businesses. The bank plans nearly US$80b in new small business lending over 10 years. The effort includes hiring about 1,000 new small business bankers and providing expanded advisory and mentorship services. The initiative also targets community investment and policy advocacy tied to small business growth and economic opportunity. For you as an investor, this move highlights...

Pratt & Whitney, an RTX subsidiary, received a multi billion dollar contract modification for F135 engines tied to the global F 35 Joint Strike Fighter program. The newly definitized, multi year award covers F135 propulsion systems and related support for international customers. RTX is increasing production speed and capacity to meet demand associated with this long duration program. For NYSE:RTX, this contract sits on top of an already sizeable defense footprint and a current share price...

Wondering if Builders FirstSource at around US$78.85 is starting to look attractive again, or if the market is still pricing in too much optimism. The stock is down around 6.9% over the past week, 24.4% over the past month, and 24.6% year to date, with a 36.9% decline over the last year and a 65.7% gain over five years. Recent headlines have focused on Builders FirstSource within broader discussions about U.S. construction activity, housing demand, and building products suppliers. This helps...

Steel Dynamics (NasdaqGS:STLD) announced that long serving directors Richard P. Teets, Jr. and Gabriel L. Shaheen plan to retire from its board at the upcoming annual meeting. The changes will reduce long term board presence and open seats for new directors once shareholders vote at the meeting. Both directors have served during key phases of the company’s development in the steel and metals recycling sector. For you as an investor, this matters because board composition shapes how Steel...

Elastic Cloud Hosted has received FedRAMP High authorization on AWS GovCloud (US), allowing use by U.S. federal agencies for highly sensitive workloads. This approval places Elastic directly into one of the most security focused cloud segments within the government and defense market. The development extends Elastic's existing government presence at a time when the NYSE:ESTC share price stands at $49.41. For investors tracking NYSE:ESTC, the FedRAMP High authorization ties a clear...

ZTO Express (Cayman) (ZTO) stock has drawn attention after recent trading left it with a one-day return near 1% and a past three months total return around 15%, prompting fresh interest in its valuation. See our latest analysis for ZTO Express (Cayman). That 1-day share price return of 1.04% comes after a 90-day share price return of 15.16%. The 1-year total shareholder return of 26.79% contrasts with weak 3 and 5 year total shareholder returns, which hints at improving but still debated...

In the wake of its recent earnings announcement, Texas Roadhouse attracted fresh attention as several analysts adopted a more positive stance despite management reiterating that beef-driven commodity inflation will weigh on profit margins through the year. The shift suggests that analysts are focusing on the resilience of Texas Roadhouse’s underlying business model even as cost pressures remain firmly in view. Next, we’ll explore how this renewed analyst optimism amid persistent beef...

Corcept Therapeutics (CORT) has received U.S. Food and Drug Administration approval for Lifyorli, to be used with nab paclitaxel in adults with platinum resistant ovarian, fallopian tube, or primary peritoneal cancer. See our latest analysis for Corcept Therapeutics. Corcept’s latest FDA approval lands after a volatile stretch, with a 12.71% 7 day share price return and a 6.78% 30 day share price return, alongside a 1 year total shareholder return of 58.53% decline. Meanwhile, 3 and 5 year...